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Background: N-acetyl proline-glycine-proline (ac-PGP) is a matrix-derived chemokine produced through the
proteolytic destruction of collagen by matrix metalloproteinases (MMPs). While upregulation and activation of
MMPs and concomitant degradation of the extracellular matrix are known to be associated with neurological injury
in ischemic stroke, the production of ac-PGP in stroke brain and its effects on neurons have not been investigated.
Findings: We examined the effects of ac-PGP on primary cortical neurons and found that it binds neuronal CXCR2
receptors, activates extracellular signal-regulated kinase 1/2 (ERK1/2), and induces apoptosis associated with caspase-3
cleavage in a dose-dependent manner. After transient ischemic stroke in rats, ac-PGP was significantly upregulated in
infarcted brain tissue.
Conclusions: The production of ac-PGP in brain in ischemia/reperfusion injury and its propensity to induce apoptosis
in neurons may link MMP-mediated destruction of the extracellular matrix and opening of the blood-brain barrier to
progressive neurodegeneration associated with the initiation and propagation of inflammation. Ac-PGP may be a novel
neurotoxic inflammatory mediator involved in sustained inflammation and neurodegeneration in stroke and other
neurological disorders associated with activation of MMPs.
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Chemokines and chemoattractant peptides direct leuko-
cytes to sites of inflammation. The CXCR2 chemokine
receptor is the primary receptor mediating neutrophil
chemotaxis, and CXCR2 and its ligands, CXCL1 (growth-
related oncogene α (GRO-α)), CXCL2 (growth-related
oncogene β (GRO-β)), and CXCL8 (interleukin-8 (IL-8))
are implicated in injury processes in stroke and other
neurological disorders. A role for the CXCR2 receptor in
ischemia/reperfusion injury is suggested by upregulation
of CXCR2 and its ligands in stroke and a reduction in in-
farction with CXCR2 antagonists [1–4]. CXCR2-mediated
infiltration of neutrophils into reperfused tissue has been* Correspondence: jwhill@salud.unm.edu
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numerous ischemia/reperfusion models, including ische-
mic stroke [4], and neuroprotection associated with
CXCR2 receptor blockade has been presumed to occur
largely indirectly through attenuation of leukocyte migra-
tion and activation.
Several studies have demonstrated neuroprotection by
inhibitors of matrix metalloproteinases (MMPs) in both
animal and in vitro stroke models [5–8]. MMPs are
believed to promote neuronal death via several mecha-
nisms. Degradation of the extracellular matrix (ECM) by
MMPs facilitates opening of the blood-brain barrier and
promotes hemorrhagic transformation and infiltration of
inflammatory cells to the ischemic site [9]. Loss of neur-
onal contact with the ECM following MMP activation
may cause neuronal death by anoikis following loss of
the contact-dependent neuronal survival signal [10].rticle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
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in neuronal apoptosis in both in vitro and in vivo stroke
models [11]. Neuroprotection by MMP inhibitors has
been proposed to result from inhibition of the aforemen-
tioned processes.
In lung inflammatory disorders, such as cystic fibrosis
(CF), persistent inflammation and neutrophilia promote
tissue damage. Recent studies have identified elevated
levels of MMP-9 in lung of CF patients. Interestingly, el-
evated levels of MMP-9 in CF lung correlate with levels
of a novel matrix-derived molecule produced by the pro-
teolytic cleavage of collagen [12]. This proline-glycine-
proline tripeptide becomes N-acetylated (ac-PGP) and
structurally mimics the CXCR2 receptor binding motif
present in pro-inflammatory chemokines such as IL-8
[13]. Ac-PGP has been shown to be a potent inducer of
neutrophil chemotaxis and stimulates neutrophils to
release MMP-9 and IL-8 [12, 14]. Thus, the production
of ac-PGP at sites of inflammation may promote tissue
injury through a forward-feeding inflammatory cycle
that persists after the initial insult. With these observa-
tions and the established role of MMP-9 in neurological
injury in stroke, we hypothesized that ac-PGP could be
produced in brain during ischemia/reperfusion injury.
To investigate the potential involvement of ac-PGP in
neuronal injury and inflammation in stroke, we charac-
terized the effects of ac-PGP on primary cortical
neurons and examined production of the molecule in
brain and plasma after ischemic stroke in animals.
Methods
Peptide synthesis
N-acetyl proline-glycine-proline (ac-PGP) (072–57) and N-
acetyl proline-glycine-glycine (ac-PGG) (custom synthesis)
were synthesized, HPLC purified, and verified by mass
spectrometry by Phoenix Pharmaceuticals.
Primary neuron culture
Primary cortical neurons were prepared from Sprague-
Dawley rat embryos on day 18 of gestation as described
previously [11], with the following modifications. Neurons
were plated in Neurobasal medium (Gibco) containing
4 % fetal bovine serum (FBS). Twenty-four hours after
plating, half of the medium was replaced with Neurobasal
medium containing 2 % B27 (Gibco) and 4 μM cytosine
arabinoside. On day 5, half of the medium was replaced
with Neurobasal medium containing 2 % B27. Experiments
were performed in quadruplicate on day 7. Replicates were
performed using neurons obtained from different animals.
Two-hour oxygen-glucose deprivation (OGD) in
glucose-free deoxygenated Hank’s buffered saline solu-
tion (HBSS) with 24-h reoxygenation was performed as
described previously [11]. Control cells were similarly
incubated in normal HBSS [11]. Unused cell culturemedium was identical in composition to that present
on day 7 of neuronal cultures (Neurobasal, 1 % FBS,
1.5 % B27). Cell extracts were prepared by sonication of
cells in phosphate-buffered saline (PBS) containing
HALT protease and phosphatase inhibitor cocktail
(Thermo Scientific) and centrifugation at 20,000×g for
10 min. Primary neurons were treated with ac-PGP and
ac-PGG peptides at the indicated doses or PBS vehicle.
Measurement of apoptosis by terminal deoxynucleotidyl
transferase-mediated dUTP nick-end labeling (TUNEL)
assay, cleaved caspase-3 immunocytochemistry, and West-
ern blots were performed as described previously [11].
Extracellular signal-regulated kinase 1/2 (ERK1/2) and
caspase-3 antibodies were obtained from Cell Signaling
Technologies, and SB225002 and anti-CXCR2 antibody
(sc-32089) were obtained from Sigma-Aldrich and Santa
Cruz Biotechnology, respectively.
Middle cerebral artery occlusion
All animal procedures were approved by the University of
New Mexico Institutional Animal Care and Use Committee
and were in compliance with federal guidelines. Animals
were anesthetized with 2 % isoflurane inhalant in 100 %
oxygen during all surgical procedures. Ninety-minute
middle cerebral artery occlusion (MCAO) was per-
formed in 290–300 g male spontaneously hypertensive
rats as described previously [15]. Infarction and
survival rates were 100 % in MCAO animals. Blood
plasma and brain tissue extracts were prepared 24 h
after reperfusion onset. Citrate plasma was prepared
from blood obtained by cardiac puncture at sacrifice
using 1.8-ml citrate plasma collection tubes (Becton-
Dickinson). Animals were transcardially perfused with
300 ml of ice-cold PBS, and brain tissue extracts (20 %
tissue) were prepared by sonication of cortical tissue
obtained within the zone of infarction (2 mm rostral to
the bregma and 3 mm lateral to the midline) in PBS
containing HALT protease and phosphatase inhibitor
cocktail and centrifugation at 20,000×g for 10 min. In-
farction was verified by 2,3,5-triphenyltetrazolium
chloride (TTC) staining [15] of a coronal brain section
adjacent to the section used to prepare infarcted cor-
tical tissue extract. Sham extracts were similarly pre-
pared from brain tissue in animals undergoing the
MCAO procedure without the insertion of an occluding
suture.
LC-MS analysis of ac-PGP
Measurement of ac-PGP in cell culture medium, cell
extracts, plasma, and brain tissue extracts by liquid
chromatography-mass spectrometry (LC-MS) was per-
formed by Alliance Pharma. Chromatographic separ-
ation was performed on a Symmetry C18 column
(100 mm× 2.1 mm, 3.5 μm) (Waters). Formic acid (0.1 %
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acid in acetonitrile was used as mobile phase B. The
chromatographic analysis was conducted using gradient
elution as follows: 10 % B (0–0.1 min), from 10 to 90 % B
(0.1–1.5 min), 90 % B (1.5–2.5 min), from 90 to 10 % B
(2.5–2.6 min), and 10 % B (2.6–4.0 min). Column
temperature was set at 25 °C. Sample injection volume
was 25 μl, and separation was performed at a flow
rate of 0.5 ml/min. An API 4000 triple quadrupole
mass spectrometer (Sciex) with TurboIonSpray inter-
face was operated in positive ionization mode with
multiple reaction monitoring. Precursor to product
ion transitions were 312.3–112.0 for ac-PGP and
329.2–162.2 for labetalol (internal standard). Sciex
Analyst software was used for data acquisition and
analysis. The calibration curve (analyte peak area/in-
ternal standard peak area versus analyte concentra-
tion) was obtained based upon the least squares
linear regression fit (y =mx + b) with a weighting
factor of 1/x2. The coefficient of determination (r2)
was > 0.99.
Statistical analysis
One-way analysis of variance (ANOVA) with Bonferroni’s
multiple comparison tests was used to establish the statis-
tical significance of comparisons between three or more
treatment groups. Comparisons of two groups were per-
formed using a two-tailed Student’s t test. All data are
shown as means with standard deviation. Statistical
significance was taken as a p value < 0.05 with a 95 %
confidence interval. Statistical analyses were performed
using GraphPad Prism software.
Results
Ac-PGP induces apoptosis in neurons through the CXCR2
chemokine receptor
In primary neurons, ac-PGP induced apoptosis in a dose-
dependent manner (Fig. 1). Control ac-PGG peptide was
non-toxic at equivalent concentrations. Blockade of the
CXCR2 receptor with a specific CXCR2 antagonist or
anti-CXCR2 antibody inhibited ac-PGP-induced neuronal
apoptosis (Fig. 2). The induction of apoptosis in neurons
was confirmed by the measurement of caspase-3 cleavage
following exposure to ac-PGP (Fig. 3a-c). Prolonged acti-
vation of ERK1/2 mitogen-activated protein (MAP) kinase
was observed in neurons treated with ac-PGP (Fig. 3d, e).
Ac-PGP is produced in primary neuron cultures and is not
significantly changed during OGD
Analysis of cell culture medium and cell extracts showed
that ac-PGP is both present at low levels in unused cell
culture medium and produced at significant levels in
neuronal cultures (Fig. 4). Following OGD, no significant
changes were observed in the level of ac-PGP in cellculture medium or cell extracts compared to controls
(Fig. 4).
Ac-PGP is significantly upregulated in brain after ischemic
stroke
Twenty-four hours after stroke, ac-PGP was significantly
upregulated in infarcted cortex compared to sham-
operated animals (Fig. 5). Ac-PGP in plasma was not sig-
nificantly changed in MCAO animals (Fig. 5).
Discussion
Evidence from several studies suggests a role for CXCR2
receptors in brain neutrophilia and evolution of infarct
volume after ischemic stroke. Studies of the CXCR1/2
inhibitor reparixin showed that receptor blockade de-
creased infarct volume, reduced neutrophil infiltration,
and improved long-term neurological outcome in rat
models of transient and permanent ischemia [2, 3]. In
another study, the CXCR1/2 antagonist G31P signifi-
cantly decreased infarction when administered after
transient MCAO in rats [4]. Further, CXCR2-binding
pro-inflammatory chemokines such as CXCL1 and IL-8
are markedly increased in brain and cerebrospinal fluid
in inflammatory neurodegenerative diseases, including
Alzheimer’s disease, Parkinson’s disease, multiple sclerosis,
and stroke, and have been proposed to be mediators of
neuronal death, primarily through pro-inflammatory
signaling [16–19]. Mounting evidence from in vitro
studies, including the results presented in this study,
suggest that ligand binding by neuronal CXCR2 recep-
tors mediates neuronal cell death directly, in addition
to promoting inflammation which may potentiate long-
term neurological damage.
A recent study demonstrated that binding of a rodent
IL-8 functional homolog, macrophage inflammatory
protein-2 (MIP-2), by CXCR2 receptors induced motor
neuron death in primary cultures [20]. In another study,
treatment of cultured neurons with IL-8 resulted in the
induction of MMP-2 and MMP-9 expression and activ-
ities, upregulation of pro-apoptotic proteins, and expres-
sion of cyclin D1 [21]. These findings suggest that
inflammatory chemokines such as IL-8 and its rodent
functional homologs may have direct pathogenic effects
in central nervous system disorders independent of their
roles in the induction of leukocyte migration and activa-
tion. Our in vitro results demonstrating the neurotox-
icity of ac-PGP confirm the induction of apoptosis by
prolonged activation of neuronal CXCR2 receptors.
Neuronal apoptosis after exposure to ac-PGP involves
cleavage of caspase-3 and activation of ERK1/2 MAP
kinase. While activation of neuronal ERK1/2 by
growth factors, ischemic preconditioning, and hypo-
thermia may mediate neuroprotection, activation of
ERK1/2 kinase by inflammatory factors in ischemic
Fig. 2 CXCR2 antagonist SB225002 and CXCR2 antibody protect
neurons against ac-PGP-induced apoptosis. a Cells exposed to 10 nM
ac-PGP for 24 h were first pretreated with SB225002 or anti-CXCR2
ligand-binding domain antibody for 30 min at the indicated dose. Cells
pretreated with all doses of SB225002 were significantly less apoptotic
than cells treated with ac-PGP only (*p < 0.0001). Cells pretreated with
1 nM SB225002 were significantly less apoptotic than cells treated with
0.01 and 0.1 nM SB225002 (#p = 0.0001 to p < 0.05). b Cells pretreated
with CXCR2 antibody at a 1:1000 (1e3) or greater dilution exhibited
significantly less apoptosis than cells treated with ac-PGP alone
(*p < 0.0001) while a 1e3 dilution produced significantly less apoptosis
than a 1e2 dilution (#p < 0.0001)
Fig. 1 Ac-PGP induces apoptosis in primary cortical neurons. a
Apoptosis in vehicle- and ac-PGP-treated neurons was measured by
TUNEL assay 24 h after treatment. Nuclei were stained with
4',6-diamidino-2-phenylindole (DAPI). Neurons are indicated by
microtubule-associated protein 2 (MAP2) staining. b Graphical
representation of actual data shown in a. A statistically significant
difference in apoptosis was found between vehicle and 0.1, 1, 10, and
100 nM ac-PGP (*p < 0.05 to p < 0.0001) and between 10 nM and 0.01,
0.1, and 1 nM ac-PGP (#p < 0.0001 to p < 0.05). c A control ac-PGG
peptide did not induce significant apoptosis in neurons at doses up
to 100 nM
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Fig. 3 Caspase-3 cleavage and activation of ERK1/2 MAP kinase in
cortical neurons exposed to ac-PGP. a Immunocytochemistry of neurons
exposed to vehicle or 10 nM ac-PGP for 24 h. Cleaved caspase-3 was
present at low levels in vehicle-treated cells and was significantly
elevated in ac-PGP-treated cells. Stages of apoptosis are indicated I–III. I
appearance of cleaved caspase-3 in the nucleus, II nuclear condensation,
III nuclear fragmentation. b Western blot of cleaved caspase-3 in
neuronal cell extracts after exposure to 0, 0.01, 0.1, 1, 10, or
100 nM ac-PGP for 24 h, lanes 1–6, respectively. c Quantitation of
Western blot data shown in b. A statistically significant difference in
cleaved caspase-3 levels between vehicle and all doses of ac-PGP was
observed (*p < 0.0001), while 10 nM ac-PGP produced a significantly
higher level of caspase-3 cleavage than 0.01 and 0.1 nM ac-PGP
(#p < 0.001 to p < 0.05). Cleaved caspase-3 levels were normalized
to full-length caspase-3. GAPDH, cytoplasmic marker glyceralde-
hyde 3-phosphate dehydrogenase. d Western blot of phospho-
ERK1/2 MAP kinase after exposure to 10 nM ac-PGP for the times
indicated in e. Phospho-ERK1/2 levels were normalized to total ERK1/
2. A statistically significant difference in ERK1/2 phosphorylation was
observed between neurons treated with vehicle and ac-PGP for 5, 15,
30, and 60 min (*p < 0.005 to p < 0.05). ERK1/2 phosphorylation was
significantly decreased at 180 min compared to 30 min (#p < 0.05)
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[22]. Interestingly, activation of ERK1/2 was similarly
observed in neutrophils upon exposure to ac-PGP,
and an inhibitor of the ERK1/2 pathway attenuated
the release of MMP-9 by neutrophils stimulated with
ac-PGP [12]. In stem cells, ac-PGP activates ERK1/2 MAP
kinase and upregulates CXCR1/2 receptor expression
[23]. In another study, ac-PGP was shown to induce
increased vascular permeability through CXCR2-mediated
induction of signaling pathways in endothelial cells [24].
Thus, in ischemia/reperfusion injury, we hypothesize that
the production of ac-PGP in brain may promote inflam-
mation and neurodegeneration through upregulation of
CXCR1/2 receptors, increased permeability of the blood-
brain barrier, recruitment and activation of leukocytes,
and direct neuronal injury mediated through prolonged
CXCR2 receptor activation.
The presence of ac-PGP in unused culture medium and
significant production of ac-PGP during normal culturing
of primary neurons may have important implications for
neuronal viability and in vitro studies of neuronal responses
to neurotoxic stressors, such as OGD. We hypothesize that
ac-PGP in unused culture medium may be of FBS origin. A
previous study demonstrated high levels of MMP-2 and
MMP-9 in conditioned neuronal culture medium which
were unchanged following OGD [11]. Thus, ac-PGP is
likely produced in neuronal cultures by the action of
MMPs on collagens or other substrates, and the lack of
a significant increase in ac-PGP in neuronal cultures
after OGD is not surprising. The increase in ac-PGP in
brain after stroke and lack of significant change in the
level of the molecule after OGD in cultured neurons
may be a fundamental difference between in vitro and
in vivo stroke models.
Fig. 4 Detection of ac-PGP in culture medium and neuronal cell extracts
after OGD. Ac-PGP was detected by LC-MS in a unused, control, and
OGD culture medium and b whole-cell extracts of control cells or cells
after 2-h OGD and 24-h reoxygenation. Ac-PGP was significantly
increased in control (*p < 0.005) and OGD (#p < 0.05) culture
medium compared to unused culture medium
Fig. 5 Detection of ac-PGP in rat brain and plasma after stroke. Ac-PGP
was detected by LC-MS in a brain extracts and b plasma from animals
undergoing 90-min MCAO with 24-h reperfusion or sham surgery.
Ac-PGP was significantly increased in brain in MCAO animals
(*p < 0.0001, n = 5 animals for each group)
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Our findings suggest a new paradigm of injury in stroke
and potentially other neurological disorders, wherein an
initial injury activates MMPs and promotes chronic
inflammation and progressive neuronal injury through
sustained production of ac-PGP, a pro-inflammatory and
neurotoxic matrix-derived chemokine. Our discovery of
the neurotoxic effects of ac-PGP and its upregulation in
infarcted cortex provides additional mechanistic ration-
ale for the reported therapeutic efficacy of CXCR2
antagonists in inflammatory neurological disorders and
warrants further studies to characterize the role of ac-
PGP in neurological injury processes in ischemic stroke.
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